← FDA DRUG APPROVALS

FDA ANDA · ANDA087792

FLUOROURACIL

Sponsor: SPECTRUM PHARMS

APPLICATION
ANDA087792
TYPE
ANDA
ORIGINAL APPROVAL
1982-10-13
LATEST ACTION
2016-12-06
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

FLUOROURACILDiscontinued
FLUOROURACIL 50MG/ML · INJECTABLE · INJECTION

Approval history

2016-12-06Labeling · Supplement 6 · standardAP
1989-08-29Manufacturing (CMC) · Supplement 5AP
1986-05-28Manufacturing (CMC) · Supplement 2AP
1982-10-13OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →